During COVID-19, T and B cell responses have been tracked in blood samples allowing identification of SARS-CoV-2-specific TH1 CD4+ and CD8+ T cell responses and the presence of SARS-CoV-2-specific neutralizing antibodies in COVID-19 patients (23) and vaccine recipients (6). This evidence concerns the gene CD8A and COVID-19.